CJC-1295 (without DAC) and Ipamorelin Interaction

Synergistic
Researched 95% confidence

CJC-1295 (without DAC) and Ipamorelin have a synergistic interaction with 95% confidence. Complementary GH release via different receptor pathways. Popular combination. Both compounds affect the gi tract and pituitary, so monitoring these systems is recommended.

Compound Profiles

CJC-1295 (without DAC)

Short-Acting Growth Hormone Releasing Hormone Analog

Binds GHRH receptors on somatotroph cells in the pituitary gland, stimulating cAMP production and physiological GH pulses. The brief 30-minute half-life allows pulsatile release versus prolonged elevation.

Half-life: 30 minutes - 2 hours Typical dose: 100-300mcg per injection growth hormone, weight loss
ghrh receptor carcinogenic riskestrogenicinsulin disruptingteratogenic
View full profile

Ipamorelin

Growth Hormone Secretagogue | Selective GHRP

Binds selectively to ghrelin receptors in pituitary gland, stimulating natural GH release with direct systemic delivery via injection, consistent GH pulse stimulation, no significant cortisol or prolactin elevation, and minimal hunger response..

Half-life: ~2 hours Typical dose: 200-300 mcg per injection growth hormone, weight loss, sleep
ghrelin receptorprolactin receptor carcinogenic riskinsulin disruptingteratogenic
View full profile

Combined Organ Load

GI Tract
low
Pituitary
low
Brain
low

Shared Safety Flags

2x 2 compounds share the carcinogenic-risk safety flag (CJC-1295 (without DAC), Ipamorelin). Monitor accordingly.
2x 2 compounds affect insulin sensitivity (CJC-1295 (without DAC), Ipamorelin). Monitor fasting glucose and HbA1c.
2x 2 compounds share the teratogenic safety flag (CJC-1295 (without DAC), Ipamorelin). Monitor accordingly.

Frequently Asked Questions

Can I take CJC-1295 (without DAC) with Ipamorelin?

Yes, CJC-1295 (without DAC) and Ipamorelin can generally be taken together. Complementary GH release via different receptor pathways. Popular combination.

Is CJC-1295 (without DAC) and Ipamorelin safe together?

Based on documented research, this combination is considered synergistic. However, shared safety flags include: carcinogenic risk, insulin disrupting, teratogenic. Monitor accordingly.

What are the interactions between CJC-1295 (without DAC) and Ipamorelin?

Complementary GH release via different receptor pathways. Popular combination. This assessment has 95% confidence and is based on documented research data.

How should I time CJC-1295 (without DAC) and Ipamorelin?

CJC-1295 (without DAC) has a half-life of 30 minutes - 2 hours and Ipamorelin has a half-life of ~2 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: CJC-1295 (without DAC) vs Ipamorelin

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.